Contraceptive care is a critical access point for ensuring that women can plan their pregnancies and for improving access to comprehensive reproductive health and rights across the United States. Making birth control pills available over the counter is one important strategy for increasing the bodily and reproductive autonomy of women and all people who can become pregnant. The Food and Drug Administration (FDA) has scheduled a joint meeting to be held on November 18 to consider its first application to make a progestin-only pill available for sale over the counter, marking a significant step forward for access.
Read the column